Average Co-Inventor Count = 11.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (7 from 4,179 patents)
2. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
3. Abbvie Inc. (3 from 822 patents)
4. Metabasis Therapeutics, Inc. (3 from 63 patents)
14 patents:
1. 9464072 - Treatment of central nervous system disorders
2. 9133145 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
3. 8940902 - Treatment of central nervous system disorders
4. 8563746 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
5. 8415354 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
6. 8410284 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
7. 8394969 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
8. 8372841 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
9. 8329914 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
10. 7880001 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11. 7071182 - Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
12. 7049307 - Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
13. 6989392 - 2-Aminoquinolines as melanin concentrating hormone receptor antagonists
14. 6921821 - Antagonists of melanin concentrating hormone receptor